Outcomes Assessment in Cancer: Quality of life in breast cancer: what have we learned and where do we go from here?

[1]  P. Ganz,et al.  Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock. , 2003, Journal of the National Cancer Institute.

[2]  P. Ganz,et al.  Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. , 2002, Journal of the National Cancer Institute.

[3]  H. Chochinov,et al.  The effect of group psychosocial support on survival in metastatic breast cancer. , 2001, The New England journal of medicine.

[4]  R. Simes,et al.  Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? , 2001, Journal of the National Cancer Institute. Monographs.

[5]  V. Helgeson,et al.  Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer. , 2001, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[6]  M. Morgan,et al.  Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Robert J. Mayer,et al.  National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.

[8]  C. Shapiro,et al.  Side effects of adjuvant treatment of breast cancer. , 2001, The New England journal of medicine.

[9]  H M Rosenberg,et al.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.

[10]  H. Kraemer,et al.  Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. , 2001, Archives of general psychiatry.

[11]  M. Nissen,et al.  Quality of life after breast carcinoma surgery , 2001, Cancer.

[12]  W. Fleischhacker,et al.  Quality of life in breast cancer patients--not enough attention for long-term survivors? , 2001, Psychosomatics.

[13]  D. Hayes,et al.  Adjuvant therapy for all patients with breast cancer? , 2001, Journal of the National Cancer Institute.

[14]  J. Holland,et al.  Social support as a buffer to the psychological impact of stressful life events in women with breast cancer , 2001, Cancer.

[15]  L. Mitrović,et al.  Patient Statement of Satisfaction With Antiemetic Treatment Is Related to Quality of Life , 2000, American journal of clinical oncology.

[16]  R. Gelber,et al.  Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Stanton,et al.  Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. , 2000, Journal of consulting and clinical psychology.

[18]  P. Ganz,et al.  Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. , 2000, Journal of the National Cancer Institute.

[19]  H. Okamura,et al.  A psychosocial group intervention for Japanese women with primary breast carcinoma , 2000, Cancer.

[20]  M. Espié,et al.  Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy , 2000, British Journal of Cancer.

[21]  J. Klijn,et al.  Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. , 2000, European journal of cancer.

[22]  J. Klijn,et al.  Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. , 2000, European journal of cancer.

[23]  M Abdolell,et al.  Cognitive function in breast cancer patients receiving adjuvant chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Ganz,et al.  Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. , 2000, Journal of the National Cancer Institute.

[25]  G. Lyman,et al.  Quality of life after adjuvant chemotherapy for breast cancer , 2000, Breast Cancer Research and Treatment.

[26]  M. Nissen,et al.  Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer. , 2000, Oncology nursing forum.

[27]  M. Speca,et al.  A randomized controlled trial of a brief psychoeducational support group for partners of early stage breast cancer patients , 2000, Psycho-oncology.

[28]  J. Bergh,et al.  Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group. , 2000, European journal of cancer.

[29]  E. Eisenhauer,et al.  Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Osoba,et al.  Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  G. Lyman,et al.  Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. , 2000, Journal of pain and symptom management.

[32]  P. Flynn,et al.  Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study , 2000, Annals of Internal Medicine.

[33]  P Kirkbride,et al.  The effects of radiation therapy on quality of life of women with breast carcinoma , 2000, Cancer.

[34]  G. Molenberghs,et al.  Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study. , 2000, European journal of cancer.

[35]  K. Mccaul,et al.  Telephone therapy for patients with breast cancer. , 2000, Oncology nursing forum.

[36]  P Novotny,et al.  Physical, psychological and social well‐being of women with breast cancer: the influence of disease phase , 2000, Psycho-oncology.

[37]  C. Tinelli,et al.  Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer. , 2000, International journal of oncology.

[38]  L. Dirix,et al.  Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Ali Montazeri,et al.  The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): Translation and validation study of the Iranian version , 2000, Quality of Life Research.

[40]  T. Delozier,et al.  High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  P. Ganz,et al.  Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Cella,et al.  Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy , 1999, Quality of Life Research.

[43]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[44]  K. Zahasky,et al.  A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment. , 1999, Oncology nursing forum.

[45]  C. Classen,et al.  Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study , 1999, Psycho-oncology.

[46]  D. Cella,et al.  Age‐related differences in the quality of life of breast carcinoma patients after treatment , 1999, Cancer.

[47]  M. Watson,et al.  Influence of psychological response on survival in breast cancer: a population-based cohort study , 1999, The Lancet.

[48]  A. Schwartz.  Fatigue mediates the effects of exercise on quality of life , 1999, Quality of Life Research.

[49]  P. Ganz,et al.  Are older breast carcinoma survivors willing to take hormone replacement therapy? , 1999, Cancer.

[50]  J. Costantino,et al.  Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  R. Greil,et al.  Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  R. Coombes,et al.  Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast , 1999, British Journal of Cancer.

[53]  P. Ganz,et al.  Predictors of sexual health in women after a breast cancer diagnosis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  D. Osoba,et al.  Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin). , 1999, Seminars in oncology.

[55]  P. Ganz,et al.  Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery , 1999, Breast Cancer Research and Treatment.

[56]  A. Kidman,et al.  A group cognitive behaviour therapy programme with metastatic breast cancer patients , 1999, Psycho-oncology.

[57]  M. Groenvold,et al.  Oral clodronate in breast cancer patients with bone metastases: a randomized study , 1999, Journal of internal medicine.

[58]  C. Rudenstam,et al.  Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study. , 1999, Acta oncologica.

[59]  E. Guadagnoli,et al.  Use of alternative medicine by women with early-stage breast cancer. , 1999, The New England journal of medicine.

[60]  P. Goodwin,et al.  Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study , 1999, Quality of Life Research.

[61]  B. Cimprich,et al.  Pretreatment symptom distress in women newly diagnosed with breast cancer. , 1999, Cancer nursing.

[62]  P. Fayers,et al.  Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? , 1999, Journal of clinical epidemiology.

[63]  R. Cody,et al.  Subtle Differences in Quality of Life After Breast Cancer Surgery , 1999, Annals of Surgical Oncology.

[64]  S. Seeber,et al.  Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial , 1999, Breast Cancer Research and Treatment.

[65]  D. Richel,et al.  Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy , 1999 .

[66]  K. Mccaul,et al.  Coping and adjustment to breast cancer , 1999, Psycho-oncology.

[67]  I. Tannock,et al.  Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost , 1999, Breast Cancer Research and Treatment.

[68]  Chiun-Sheng Huang,et al.  Measurement of the quality of life during different clinical phases of breast cancer. , 1999, Journal of the Formosan Medical Association = Taiwan yi zhi.

[69]  M. B. Walker,et al.  Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy , 1999, British Journal of Cancer.

[70]  A. Liberati,et al.  Quality of life in women with recurrent breast cancer , 1999, Breast Cancer Research and Treatment.

[71]  V. Velanovich,et al.  Quality of life of breast cancer patients with lymphedema. , 1999, American journal of surgery.

[72]  W. T. Sawyer,et al.  Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support , 1999, Psycho-oncology.

[73]  I. Wiklund,et al.  Quality of life in newly diagnosed cancer patients. , 1999, Journal of advanced nursing.

[74]  P. Ganz,et al.  Quality of life of African‐American and white long term breast carcinoma survivors , 1999, Cancer.

[75]  K. Holli,et al.  Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  R. Rubens,et al.  Do patients with advanced breast cancer benefit from chemotherapy? , 1998, British Journal of Cancer.

[77]  G. Lockwood,et al.  A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer , 1998, Psycho-oncology.

[78]  S. Bloch,et al.  Psychological morbidity and quality of life in Australian women with early‐stage breast cancer: a cross‐sectional survey , 1998, The Medical journal of Australia.

[79]  I. Wiklund,et al.  Nursing intervention to increase hope and quality of life in newly diagnosed cancer patients. , 1998, Cancer nursing.

[80]  D. Tu,et al.  Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  R. Gray,et al.  Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  J. de Haes,et al.  Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. , 1998, Annals of Oncology.

[83]  J. Dunn,et al.  Domains of distress: the experience of breast cancer in Australia. , 1998, Oncology nursing forum.

[84]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[85]  G. Lyman,et al.  Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  G. Apolone,et al.  Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[87]  G. Wyatt,et al.  Physical and psychosocial outcomes of midlife and older women following surgery and adjuvant therapy for breast cancer. , 1998, Oncology nursing forum.

[88]  P. Jacobsen,et al.  Posttraumatic Stress Disorder Symptoms After Bone Marrow Transplantation for Breast Cancer , 1998, Psychosomatic medicine.

[89]  M. Cordova,et al.  Hot flashes in postmenopausal women treated for breast carcinoma , 1998, Cancer.

[90]  W. T. Sawyer,et al.  Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  D. Osoba,et al.  Missing quality of life data in cancer clinical trials: serious problems and challenges. , 1998, Statistics in medicine.

[92]  C. Koopman,et al.  Social support, life stress, pain and emotional adjustment to advanced breast cancer , 1998, Psycho-oncology.

[93]  Gail R. Luera,et al.  Types of spiritual well-being among persons with chronic illness: their relation to various forms of quality of life. , 1998, Archives of physical medicine and rehabilitation.

[94]  S. Stewart,et al.  Intrusiveness of illness and quality of life in young women with breast cancer , 1998, Psycho-oncology.

[95]  P. Goodwin,et al.  Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. , 1998, European journal of cancer.

[96]  S. Rodenhuis,et al.  Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.

[97]  M. Dorval,et al.  Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  S. Schraub,et al.  The development of a French version of a questionnaire on the quality of life in cancerology (Functional Living Index-Cancer: FLIC). , 1998, Bulletin du cancer.

[99]  N K Aaronson,et al.  Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). , 1998, European journal of cancer.

[100]  R. Gelber,et al.  Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[101]  D. Tate,et al.  Quality of life issues among women with physical disabilities or breast cancer. , 1997, Archives of physical medicine and rehabilitation.

[102]  C. Fulton.  The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. , 1997, European journal of cancer care.

[103]  D. Osoba,et al.  Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30 , 1997, Supportive Care in Cancer.

[104]  S. Singletary,et al.  Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment. , 1997, Alternative therapies in health and medicine.

[105]  H. P. Graversen,et al.  A comparative study of post-operative psychosocial function in women with primary operable breast cancer randomized to breast conservation therapy or mastectomy. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[106]  K. Pritchard,et al.  Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[107]  M. Atkinson,et al.  Computerized quality-of-life screening in an oncology clinic. , 1997, Cancer practice.

[108]  D S Tulsky,et al.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  L. Fallowfield,et al.  Offering choice of surgical treatment to women with breast cancer. , 1997, Patient education and counseling.

[110]  A. Buzdar,et al.  A Phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma , 1997 .

[111]  L. Azzarello,et al.  Quality of life following bone marrow transplantation for breast cancer: a comparative study , 1997, Bone Marrow Transplantation.

[112]  C. Classen,et al.  Coping styles associated with psychological adjustment to advanced breast cancer. , 1996, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[113]  A. Seidman,et al.  An exploratory study of frequent pain measurement in a cancer clinical trial , 1996, Quality of Life Research.

[114]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  N. Frasure-smith,et al.  Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[116]  D. Mant,et al.  Routine follow up of breast cancer in primary care: randomised trial , 1996, BMJ.

[117]  D. Hurd,et al.  Quality of life in breast cancer patients before and after autologous bone marrow transplantation. , 1996, Bone marrow transplantation.

[118]  M. Andrykowski,et al.  Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: a controlled comparison. , 1996, Journal of clinical epidemiology.

[119]  G. Azzarello,et al.  The impact of a psychological intervention on quality of life in non-metastatic breast cancer. , 1996, European journal of cancer.

[120]  J. Forbes,et al.  Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer , 1996, The Lancet.

[121]  K. Weinfurt,et al.  Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[122]  T. Ahles,et al.  Psychologic and neuropsychologic impact of autologous bone marrow transplantation. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  E. Hamrin,et al.  Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30 , 1996, Quality of Life Research.

[124]  S. Kaasa,et al.  The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. , 1995, European journal of cancer.

[125]  M. Cordova,et al.  Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. , 1995, Journal of consulting and clinical psychology.

[126]  C. Redmond,et al.  Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. , 1995, Journal of the National Cancer Institute.

[127]  L. Norton,et al.  Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. , 1995, Journal of the National Cancer Institute.

[128]  C. Miaskowski,et al.  The problem of pain in outpatients with breast cancer. , 1995, Oncology nursing forum.

[129]  G. Donaldson,et al.  Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer. , 1995, Seminars in oncology.

[130]  A J Asbury,et al.  Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer. , 1995, British journal of anaesthesia.

[131]  R H Brook,et al.  Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.

[132]  D. Osoba,et al.  Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer , 1994, Quality of Life Research.

[133]  D. Arathuzik.  Effects of cognitive-behavioral strategies on pain in cancer patients. , 1994, Cancer nursing.

[134]  S. Kaasa,et al.  The EORTC Modular Approach to Quality of Life Assessment in Oncology , 1994 .

[135]  M. Indelli,et al.  Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. , 1994, JAMA.

[136]  J. Graydon.  Women with breast cancer: their quality of life following a course of radiation therapy. , 1994, Journal of advanced nursing.

[137]  C. Sherbourne,et al.  The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups , 1994, Medical care.

[138]  P. Ganz,et al.  Cancer Inventory of Problem Situations , 1993 .

[139]  D. Lomas,et al.  Computed tomography or magnetic resonance imaging for axillary symptoms following treatment of breast carcinoma? A randomized trial. , 1993, Clinical radiology.

[140]  J. Abrams,et al.  Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[141]  J. Pater,et al.  A validation study of the domains of the core EORTC Quality of Life Questionnaire , 1993, Quality of Life Research.

[142]  A. Goldhirsch,et al.  The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials , 1993, Supportive Care in Cancer.

[143]  M. Piccart,et al.  Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[144]  M. Clavel,et al.  Improved control of emesis and quality of life with ondansetron in breast cancer. , 1993, Oncology.

[145]  P. Ganz,et al.  Predicting Psychosocial Risk in Patients With Breast Cancer , 1993, Medical care.

[146]  P. Ganz,et al.  Characteristics of women at risk for psychosocial distress in the year after breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[147]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[148]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[149]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[150]  L. Fallowfield,et al.  Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. , 1993, British Journal of Cancer.

[151]  J F Forbes,et al.  Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[152]  G H Guyatt,et al.  Measuring health status: what are the necessary measurement properties? , 1992, Journal of clinical epidemiology.

[153]  C. Carver,et al.  Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[154]  G. Maguire,et al.  Psychological morbidity in the first year after breast surgery. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[155]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[156]  A. Howell,et al.  Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life. , 1992, European journal of cancer.

[157]  P. Ganz,et al.  Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer. , 1992, Journal of clinical epidemiology.

[158]  E. Paci.  Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist , 1992, Quality of Life Research.

[159]  P. Ganz,et al.  Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? , 1992, Cancer.

[160]  T. Ibbotson,et al.  Further development of a quality of life measure for cancer patients: The rotterdam symptom checklist (revised) , 1992 .

[161]  P. Ganz,et al.  The CARES: a generic measure of health-related quality of life for patients with cancer , 1992, Quality of Life Research.

[162]  P. Butow,et al.  On the receiving end. IV: Validation of quality of life indicators. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[163]  P. Ganz,et al.  CAncer rehabilitation evaluation system–short form (CARES‐SF). A cancer specific rehabilitation and quality of life instrument , 1991, Cancer.

[164]  A. Howell,et al.  Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. , 1991, British Journal of Cancer.

[165]  A. Howell,et al.  Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. , 1991, British Journal of Cancer.

[166]  J. de Haes,et al.  The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[167]  L. Fallowfield,et al.  Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone , 1991, The British journal of surgery.

[168]  A. Zwinderman,et al.  The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. , 1991, European journal of cancer.

[169]  M. Watson,et al.  Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients , 1991, Psychological Medicine.

[170]  R. Heinrich,et al.  Development of a comprehensive quality of life measurement tool: CARES. , 1990, Oncology.

[171]  H. Kraemer,et al.  EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER , 1989, The Lancet.

[172]  W. Wolberg,et al.  Psychosexual adaptation to breast cancer surgery , 1989, Cancer.

[173]  M. Lippman,et al.  Breast conservation versus mastectomy: distress sequelae as a function of choice. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[174]  R Yancik,et al.  Breast cancer in aging women. A population‐based study of contrasts in stage, surgery, and survival , 1989, Cancer.

[175]  G. Guyatt,et al.  Quality of life in stage II breast cancer: an instrument for clinical trials. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[176]  P. Pietroni,et al.  Relaxation and imagery in the treatment of breast cancer. , 1988, BMJ.

[177]  M. Kemeny,et al.  Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer , 1988, Cancer.

[178]  I. Tannock,et al.  A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[179]  M. Tattersall,et al.  Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. , 1987, The New England journal of medicine.

[180]  V. Flack,et al.  Rehabilitation needs and breast cancer: The first month after primary therapy , 1987, Breast Cancer Research and Treatment.

[181]  J. de Haes,et al.  The effect of radical and conserving surgery on the quality of life of early breast cancer patients. , 1986, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[182]  W. Wolberg,et al.  Psychological distress among women with breast problems , 1986, Cancer.

[183]  N. Boyd,et al.  The development of a method for assessing the quality of life of cancer patients. , 1984, British Journal of Cancer.

[184]  A McMurray,et al.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[185]  A. Zigmond,et al.  The Hospital Anxiety and Depression Scale , 1983, Acta psychiatrica Scandinavica.

[186]  D. Spiegel,et al.  Group Support for Patients With Metastatic Cancer: A Randomized Prospective Outcome Study , 1981 .

[187]  L. Radloff.  The CES-D Scale , 1977 .

[188]  M. Baum,et al.  EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCER , 1976, The Lancet.

[189]  D. Bodurka,et al.  Quality of Life and Sexual Functioning , 2006 .

[190]  B. Ferrell,et al.  An evaluation of the quality of life among long-term survivors of breast cancer , 2005, Breast Cancer Research and Treatment.

[191]  Patricia A. Ganz,et al.  Breast cancer survivors: Psychosocial concerns and quality of life , 2005, Breast Cancer Research and Treatment.

[192]  M. Groenvold,et al.  Quality of life of Danish women: Population-based norms for the EORTC QLQ-C30 , 2004, Quality of Life Research.

[193]  M. King,et al.  Quality of life three months and one year after first treatment for early stage breast cancer: Influence of treatment and patient characteristics , 2004, Quality of Life Research.

[194]  Mohamed Abdolell,et al.  Perception of quality of life by patients, partners and treating physicians , 2004, Quality of Life Research.

[195]  S. Jansen,et al.  Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy , 2004, Quality of Life Research.

[196]  P. Goss.  Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor , 2004, Breast Cancer Research and Treatment.

[197]  Y. Brandberg,et al.  Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms. , 2000, Acta oncologica.

[198]  P. Goss,et al.  The Effects of Type of Surgery and Time on Psychological Adjustment in Women After Breast Cancer Treatment , 2000, Annals of Surgical Oncology.

[199]  J. Hanfelt,et al.  A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[200]  L. Fallowfield,et al.  Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? , 1999, European journal of cancer.

[201]  G. Lockwood,et al.  Psychological response to long term group therapy: a randomized trial with metastatic breast cancer patients , 1999, Psycho-oncology.

[202]  L Cohen,et al.  Physical and psychological morbidity after axillary lymph node dissection for breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[203]  I. Tannock,et al.  Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[204]  H. Strander,et al.  Effects of a nursing intervention on subjective distress, side effects and quality of life of breast cancer patients receiving curative radiation therapy--a randomized study. , 1999, Acta oncologica.

[205]  M. Somerfield,et al.  Can 40 seconds of compassion reduce patient anxiety? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[206]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[207]  P. Ganz,et al.  Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[208]  R. Yancik.  Epidemiology of cancer in the elderly. Current status and projections for the future. , 1997, Rays.

[209]  A. Dobson,et al.  A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index--cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30). , 1996, Journal of clinical epidemiology.

[210]  L. Wallace,et al.  The quality of life of early breast cancer patients treated by two different radiotherapy regimens. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

[211]  R. Gelber,et al.  Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group. , 1992, European journal of cancer.

[212]  D. Kerr,et al.  Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer. , 1992, Oncology.

[213]  J. Kievit,et al.  Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. , 1990, European journal of cancer.

[214]  P. Ganz,et al.  Assessing the quality of life--a study in newly-diagnosed breast cancer patients. , 1990, Journal of clinical epidemiology.

[215]  P. Ganz,et al.  Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[216]  W. Wolberg,et al.  Factors influencing options in primary breast cancer treatment. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[217]  J. D. Haes,et al.  Klachtenlijst voor kankerpatiënten, eerste ervaringen , 1983 .

[218]  D. Christensen.  Postmastectomy couple counseling: an outcome study of a structured treatment protocol. , 1983, Journal of sex & marital therapy.

[219]  B. Meyerowitz.  Psychosocial correlates of breast cancer and its treatments. , 1980, Psychological bulletin.